Ye Xiaoping

Early Life and Background

Ye Xiaoping, born in China, holds a Ph.D. from Oxford University and an EMBA from Peking University. Before his entrepreneurial endeavors, he served as an executive at the Swiss pharmaceutical giant Roche.

Rise to Success

Ye identified a critical need for high-quality clinical trial services in China and founded Hangzhou Tigermed Consulting in 2004. Under his leadership, Tigermed has become a leading contract research organization (CRO) in the pharmaceutical industry, supporting both multinational and domestic pharmaceutical companies in navigating the drug approval process. Tigermed's expansion included listings on the Shenzhen Stock Exchange and later in Hong Kong, and global acquisitions in the US and Europe, solidifying its role in the global drug development ecosystem.

Key Business Strategies

Ye's strategy focused on building a comprehensive CRO that supports drug development from clinical trials to data management and statistical analysis. This approach has made Tigermed a key partner for pharmaceutical companies seeking to innovate in China. His leadership emphasizes innovation and global expansion, positioning Tigermed as a significant player in the global pharmaceutical industry.

Philanthropy

Information regarding Ye Xiaoping's philanthropy is unavailable in the search results.